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Abstract
Background: The objective of the study was to describe the baseline health-related quality of life (HRQOL) in a
cohort of children and adolescents with type 1 diabetes mellitus (T1DM), and analyze its associated clinical and
sociodemographic factors, assessing HRQOL through internet.
Methods: This was a descriptive study of 136 patients with T1DM from 5 hospitals in Catalonia, Spain (72 girls,
mean age 13.4 years (range 8–19). Inclusion criteria were more than 6 months from diagnosis, more than 8 years
old and without cognitive problems. Sociodemographic (age, sex, family level of education, type of family and
origin) and clinical variables (type of insulin therapy, duration of disease, adherence to treatment, body mass index
and HbA1c) were collected. HRQOL was assessed using the EuroQol-5D (EQ-5D-Y) and KIDSCREEN, collected via
web. Mental health status was assessed using the Strengths and Difficulties Questionnaire. Multiple linear regression
models were adjusted.
Results: Physical-well-being mean scores were lower (worse) than the European average (<50) and especially in
girls, older children (>11 years old), those from single-parent families, and those with low adherence. Older children
and patients with poor metabolic control (HbA1c >7,5% [58 mmol/mol]) showed worse scores in the KIDSCREEN-10
index. Similar results were observed with the EQ-5D-Y. Multivariate models showed that age, single-parent families,
adherence and mental health were the most influential factors.
Conclusions: Diabetic patients report similar HRQOL than the population of the same age with slightly worse
physical well-being. The study shows some factors to be taken into account to improve HRQOL, and also the
feasibility of using web to collect information in clinical practice.
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Background
There is a growing interest in the study of health-related
quality of life (HRQOL), which has become an important
end-point measure from the clinical and epidemiological
point of view [1].
Type 1 Diabetes Mellitus (T1DM) is a chronic disease
that affects all aspects of patient’s life and especially
psychologically and therefore HRQOL. The management
of T1DM is complex, requiring a high degree of responsi-
bility and self-control to achieve an adequate metabolic
control. Key aspects to succeed are the support of a multi-
disciplinary team, education in disease management with
decision-making capacity, and exploit the possibilities
offered by new technologies without forgetting the
emotional sphere of the patient and family. In fact,
treatment guidelines recommend routine screening for
emotional status and family relationships [2]. On the
other hand, hormonal and psychosocial changes that
occur during puberty make this stage a difficult time
with high metabolic instability, and many adolescents
experience deterioration in metabolic control [3, 4].
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Assessment of HRQOL in clinical practice is import-
ant in order to evaluate the course of the disease, early
detection of problems, and to determine what type of
insulin therapy would be adequate to maintain accept-
able metabolic control with less impact on HRQOL in
each patient [2, 4].
Previous studies have shown that girls, older children,
and specific sociodemographic factors such as single-
parenthood, lower family income or minority status would
be associated with poor metabolic control and worse
HRQOL [2]. Studies addressed to analyze emotional and
psychosocial aspects such as self-management and self-
esteem, resilience, and parenting showed a positive in-
fluence on HRQOL, although interventions need to be
tailored to the specific needs of children and families
[5]. A systematic review assessed HRQOL in children
with T1DM [6] and its potential help in clinical man-
agement. This review describes HRQOL in groups of
patients comparing with control groups, and also analyzing
HRQOL with specific instruments. The results of this
review show that overall diabetic children have similar
HRQOL compared to healthy peers but reported disease
specific problems. Gender and age differences were also
found. Studies included in this review were mainly
descriptive and no studies were included comparing
with general population data.
A few studies were carried out in Spain addressing
HRQOL in children with T1DM [7], Studies analyzing
clinical factors associated with HRQOL in patients with
T1DM, and on the use of internet to collect information
[8] and its usefulness on clinical practice [9–11] were
carried out in other contexts.
The aim of this study was to describe the HRQOL in
Spanish children and adolescents with T1DM and analyze
its associated clinical and sociodemographic factors, asses-
sing HRQOL through internet. This study represents the
baseline assessment of an intervention to evaluate use of
generic HRQOL measures administered via internet in
clinical practice. According to previous studies it was
expected that children from vulnerable families, with poor
metabolic control, and/or poor mental health would show
worse HRQOL.
Methods
Participants and procedures
Patients were consecutively recruited from a list of 205
potential candidates (104 girls) between 8 and 19 years
old with T1DM attending outpatient pediatric endocrin-
ology of 5 hospitals in the Barcelona province area,
Spain (7 pediatric endocrinologists participated in the
study), between July and December 2014. Exclusion cri-
teria were less than 6 months from diagnosis of T1DM,
less than 8 years old at the time of recruitment, cogni-
tive problems that prevented comprehension of the
questionnaires, and patients who declined to participate
in the study.
Families that fulfilled inclusion criteria were provided
with a letter explaining the characteristics of the project
and the need to access to digital questionnaires 48 h
before the follow-up visits. After agreeing to participate
in the study, parents answered a paper questionnaire
administered during this visit including information on
sociodemographics and family’s variables. Before the next
quarterly routine visit, a reminder was sent by email and/
or telephone to the family and patient.
Study variables
Sociodemographic variables were collected from parents,
clinical variables came from clinical records, and HRQOL,
mental health and adherence to treatment came from the
self-administered online questionnaire.
Sociodemographic variables were: age, sex, and the
highest family level of education (primary, secondary or
university). The variable family origin (native vs immigrant
status) was based on the country where the child and
parents were born. It was considered as immigrants if the
child and/or both parents were born in a developing
country (Asia, Africa, Latin America, or Eastern European
country). Family type (single-parent vs bi-parental family),
and hospital were also collected.
Clinical variables analyzed were: type of insulin therapy
(multiple daily injections [MDI] or pump therapy, only in
2 cases); use of insulin bolus calculator or not; and time
since diagnoses (in years). Decompensation in the last
3 months was assessed as significant hypoglycemia
(<60 mg/dl with decreased level of consciousness re-
quiring glucagon or the help of others to be reversed),
and significant hyperglycemia (>400-450 mg/dl which
required action by the professionals). Diabetes ketoacidosis
was also collected. The HbA1c was used as a measure of
metabolic control by determination in capillary blood
(DCA 2000 Bayer/Siemens®) or serum in an analytical
laboratory (HPLC). Weight, height and body mass index
(BMI, Z score) [12] was also collected.
The web-version of the questionnaires was developed
through a generic internet tool using Ruby on Rails ap-
plications and MySQL database (http://rubyonrails.org).
The self-administered questionnaire included the
internet versions of the Euroqol-5D-Y (EQ-5D-Y) and
KIDSCREEN-27 and KIDSCREEN-10 index as measures
of HRQOL.
The self-reported EQ-5D-Y [13] descriptive system
consists of 5 dimensions (mobility, self-care, usual activ-
ities, pain-discomfort and anxiety-depression) with 3-levels
Likert response scales (no problems, moderate problems
and serious problems) and a visual analogue scale (VAS)
on the general health status from 0 (worst health status) to
100 (best health status possible). The Internet Catalan and
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Spanish versions of the eEQ-5D-Y have demonstrated ac-
ceptable reliability and validity in the Spanish population,
and similar to the paper version [14].
The self-reported KIDSCREEN-27 [15] was assessed
by its 5 dimensions: physical well-being (5 items),
psychological well-being (7 items), autonomy and rela-
tionships with parents (7 items), social support and
relationship with friends (4 items) and school environment
(4 items). Responses were categorized into 5 options
Likert scales that assess the frequency or intensity of the
attribute, with a recall-period of 1 week in most questions.
The scores are standardized to a mean of 50 and a stand-
ard deviation (SD) 10, from a reference sample of 22,000
European children and adolescents. The KIDSCREEN-10
index was also included as a summary measure. The inter-
net Spanish and Catalan versions of the questionnaire
have demonstrated acceptable reliability and validity in
this population, similar to the paper version [16].
Children’s mental health status was assessed using the
Strengths and Difficulties Questionnaire (SDQ), a brief
behavioral screening questionnaire for children and ado-
lescents that asks about their mental health symptoms
and positive attitudes [17]. The instrument consists of
25 items measuring 5 dimensions. All items are scored
on a three point scale (0 = not true, 1 = somewhat true,
and 2 = certainly true). Items in the 4 problem dimensions
are summed to give a total difficulties score ranging from
0 (no problems) – 40 (maximum problems). Higher scores
indicate more problems. The Spanish and catalan versions
have been shown to be reliable and valid [18].
Adherence to treatment in the month prior to the
interview was assessed by two questions: How often
have you checked your blood sugar?; and: How often did
you do a blood sugar check within 2–3 h after a meal?
Both questions included 7 and 5 frequency Likert-scale
answer categories, respectively. Patients were categorized
into high adherence if they answered a frequency of
control of glucose level 3 or more times per day, and
also a frequency of blood sugar check within 2–3 h after
a meal at least 3 or more times a week.
Statistical analysis
Mean scores of the KIDSCREEN-27 dimensions and
KIDSCREEN-10 index and its 95% confidence interval
(95% CI) were computed and compared with the average
of European population. The distribution of health states
were also analyzed according to the descriptive system of
EQ-5D-Y. Mean scores of HRQOL, both the KIDSCREEN
and VAS score, according to sociodemographic factors,
adherence and control of diabetes, and clinical variables
were assessed by Student t test, Mann–Whitney U, or
ANOVA according to the characteristics of analyzed vari-
ables. Standardized mean differences (effect size, ES) esti-
mated as the difference between the means divided by
pooled standard deviation, were computed to analyze the
magnitude of differences [19].
Effect sizes of 0.2–0.5 were considered small; those
between 0.51 and 0.8 moderate, and those over 0.8 were
considered large.
Multiple linear regression models were adjusted to
analyze the influence of factors associated with HRQOL
controlling for socio-demographic, clinical factors, and
mental health. Interactions terms between clinical and
sociodemographic factors were also explored. Results of
regressions in terms of B coefficients can be interpreted
as a modification (increase [+] or decrease [−]) on the
dependent variable (a given dimension of HRQOL) for
every unit of change in the predictor variable (e.g. age).
Bonferroni correction was used to control for multiple
comparisons. Program STATA.11 software versions were
used in the analysis.
Results
One hundred thirty six patients were included in the
study (participation rate 65.5%). Sixty one patients were
not included due to change of address, transfer to the
adult unit, or not attending follow-up visits, while 8
patients rejected their participation in the study. There
were no significant differences in terms of age, gender or
years of disease progression among patients who entered
in the study and those not included.
Table 1 shows the clinical and demographic character-
istics of the sample. The average age of participants was
13.4 years; 52.9% were girls; 15.7% came from single-
parent families; 6% of immigrant families, and 19.4% of
parents had university degree. In 4 cases the question-
naires were filled out in a waiting time previous to the
visit given the absence of internet at home.
The mean time of disease progression was 5 years,
with 39.7% (n = 54) longstanding (>5 years), and 19.9%
less than 1 year. The average HbA1c level was 7.65% (SD ±
1.3; 60 mmol/mol; SD ± 13.2); 52.2% of patients had good
metabolic control (HbA1c <7.5%; 58 mmol/ml), with an
average of 8.64% (SD ±1.22; 71 mmol/ml) in those with
poor metabolic control and 6.74% (SD ± 0.59; 50 mmol/ml)
in those with good metabolic control; 1.5% of patients used
pump therapy, the rest received MDI therapy; 81.5% of
patients had no significant change in insulin therapy during
the 3 months prior to baseline assessment. Five percent
started to use an insulin bolus calculator, and 52.9% had a
high level of adherence to treatment. There were 3
cases of significant hypoglycemia in the last three months.
Mean score on mental health (SDQ total difficulties score)
was 10.65.
The results of the KIDSCREEN-27 and the KIDSCREEN-
10 mean scores, and VAS are shown in Table 2. Physical-
well-being scores were lower than the European average
(<50) and especially in girls, older children (>11y), those
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from single-parent families, and those with low adherence
to the treatment. Older children (>11y = 48.3, [95% CI]
46.7–49.9), and patients with poor metabolic control (48.0;
95% CI 46.3–49.6) presented worse scores in the
KIDSCREEN-10 index. On the other hand, patients with
good metabolic control and shorter duration of disease
(<5 years), showed better scores. Similar results were
observed with the VAS. Table 3 shows the magnitude of dif-
ferences (ES) on HRQOL according to sociodemographic
and clinical variables. Large ES were seen on age, changes
on treatment during the last 3 months, hyperglycemia and
hypoglycemia.
Children and adolescents showed relatively few health
problems in the EQ-5D-Y dimensions, although 33.6%
reported having pain or discomfort and 26.1% reported
having anxiety or depression; 50% of children scored the
best possible health state on to the descriptive EQ-5D-Y
system (data not shown).
Multivariate models of HRQOL are shown in Table 4.
Age, single-parent families, adherence to treatment, and
mental health were the influential factors on HRQOL. Sta-
tistically significant associated factors to the KIDSCREEN-
10 were age (B coefficient = −0.93); single-parent families
(B = −15.2); and mental health (B = −0.7). An interaction
was found between age and type of family, so older ages
showed less influence of single parent families on the
KIDSCREEN-10 index of HRQOL (B = 1.02 for age and
type of family interaction).
Discussion
This study shows that children and adolescents with
T1DM report similar HRQOL than the general popula-
tion of the same age and gender, although slightly worse
physical well-being than their peers. The study shows
that the type of family, mental health and treatment
adherence should be taken into account to improve
HRQOL in these patients. It also shows the feasibility of
assessing HRQOL via Internet, and its use as a daily
clinical practice tool in a cohort of children, reinforcing
the results of previous research [9, 10].
In general, HRQOL were similar than the general
population, as it was shown in a previous systematic
review [6]. In our study, younger patients had better
HRQOL scores; and girls had lower HRQOL scores in
virtually all dimensions, indicating greater vulnerability
and similar results than in other studies [20, 21]. Thus,
the study suggests the need to assess and monitor po-
tential problems, especially in adolescence. Moreover,
recent guidelines from ISPAD have recommended
routine assessment of HRQOL with adequate tools [2].
Comparing our results with Spanish general population
data Physical well-being dimension score was 0.5 stand-
ard deviation lower (worse) than the reference popula-
tion, which represent a meaningful difference [22].
Table 1 Sociodemographic and clinic characteristics of participants
Sociodemographic variables N Mean (SD) or %
Age
Mean 136 13.45 (2.9)
8–11y 36 26.5
12–19y 100 73.5
Sex
Boys 64 41.1
Girls 72 52.9
Type of family
Biparental 113 84.3
Monoparental 21 15.7
Highest family level of education
Primary school 54 40.3
Secondary school 54 40.3
University degree 26 19.4
Origin
Native 128 94.1
Immigrant 8 6.0
Clinical variables
Time w/diagnoses (years) 136 5.04 (3.73)
> 5 years 54 39.7
≤ 5 years 82 60.3
BMI (Z score) 136 0.24 (0.9)
HbA1c 136 7.65 (1.34)/60 mmol/mol
(14.6)
> 7.5% (58 mmol/mol) 65 47.8
≤ 7.5% 71 52.2
Mental health
SDQ 136 10.64 (5.28)
Adherence
High 64 47.1
Low 72 52.9
Changes during the last 3 months
No changes on treatment 110 81.5
Changes on diet/nutrition 18 13.3
Bolus calculator 7 5.2
Hypoglycemia
Yes 3 2.2
No 133 97.8
Hyperglycemia
Yes 10 7.4
No 126 92.6
Missing values: level of education (2); type of family (2); changes during the
last 3 months (1)
SD Standard deviation, BMI body mass index, HBAc1 Glycated hemoglobin,
DSMQ Diabetes Self Management Questionnaire
Murillo et al. BMC Pediatrics  (2017) 17:16 Page 4 of 9
Ta
b
le
2
KI
D
SC
RE
EN
-2
7,
KI
D
SC
RE
EN
-1
0
In
de
x
an
d
Vi
su
al
an
al
og
ue
sc
al
e
(V
A
S)
sc
or
es
an
d
its
95
%
co
nf
id
en
ce
in
te
rv
al
(9
5%
CI
)a
cc
or
di
ng
to
so
ci
od
em
og
ra
ph
ic
an
d
cl
in
ic
al
va
ria
bl
es
Ph
ys
ic
al
w
el
lb
ei
ng
Ps
yc
ho
lo
gi
ca
lw
el
l-b
ei
ng
Pa
re
nt
s/
A
ut
on
om
y
Pe
er
s
Sc
ho
ol
KI
D
SC
RE
EN
-1
0
in
de
x
VA
S
To
ta
l
46
.4
(4
4.
8–
48
.0
)
49
.7
(4
8.
0–
51
.3
)
50
.5
(4
9.
1–
51
.9
)
53
.6
(5
2.
1–
55
.2
)
52
.0
(5
0.
4–
53
.6
)
49
.6
(4
2.
2–
51
.0
)
80
.2
(7
7.
6–
82
.7
)
A
ge 8
–1
1y
49
.2
(4
6.
3–
52
.0
)
52
.5
(4
9.
7–
55
.4
)
50
.9
(4
8.
3–
53
.5
)
55
.6
(5
2.
7–
58
.5
)
56
.1
(5
3.
3–
58
.9
)
53
.3
(5
0.
6–
56
.1
)
85
.9
(8
2.
3–
89
.5
)
12
–1
9y
45
.4
(4
3.
5–
47
.3
)
48
.6
(4
6.
7–
50
.6
)
50
.4
(4
8.
8–
52
.1
)
52
.9
(5
1.
1–
54
.8
)
50
.6
(4
8.
7–
52
.4
)
48
.3
(4
6.
7–
49
.9
)
78
.1
(7
5.
1–
81
.2
)
Se
x B
oy
s
47
.4
(4
5.
3–
49
.5
)
50
.0
(4
8.
1–
51
.9
)
50
.2
(4
8.
3–
52
.0
)
54
.3
(5
2.
1–
56
.4
)
49
.7
(4
7.
8–
51
.7
)
49
.6
(4
7.
9–
51
.2
)
80
.0
(7
6.
4–
83
.5
)
G
irl
s
45
.6
(4
3.
2–
48
.0
)
49
.4
(4
6.
7–
52
.0
)
50
.9
(4
8.
8–
52
.9
)
53
.1
(5
0.
8–
55
.3
)
54
.0
(5
1.
6–
56
.4
)
49
.7
(4
7.
4–
51
.9
)
80
.3
(7
6.
8–
83
.9
)
Ty
pe
of
fa
m
ily
Bi
pa
re
nt
al
47
.4
(4
5.
6–
49
.1
)
50
.1
(4
8.
3–
51
.8
)
51
.0
(4
9.
5–
52
.5
)
54
.0
(5
2.
3–
55
.7
)
52
.3
(5
0.
6–
54
.1
)
49
.9
(4
8.
4–
51
.5
)
81
.4
(7
8.
7–
84
.0
)
M
on
op
ar
en
ta
l
41
.5
(3
8.
2–
44
.1
)
47
.9
(4
2.
6–
53
.3
)
47
.9
(4
3.
9–
51
.9
)
50
.5
(4
6.
4–
50
.7
)
50
.0
(4
5.
9–
54
.1
)
47
.4
(4
3.
9–
51
.0
)
75
.5
(6
9.
2–
81
.9
)
H
ig
he
st
fa
m
ily
le
ve
lo
f
ed
uc
at
io
n
Pr
im
ar
y
sc
ho
ol
45
.2
(4
2.
4–
48
.1
)
49
.0
(4
6.
3–
51
.8
)
49
.5
(4
7.
5–
51
.6
)
52
.8
(5
0.
3–
55
.3
)
52
.0
(4
9.
4–
54
.5
)
49
.2
(4
6.
8–
51
.6
)
80
.2
(7
6.
2–
84
.1
)
Se
co
nd
ar
y
sc
ho
ol
46
.7
(4
4.
2–
49
.3
)
50
.2
(4
7.
3–
53
.1
)
51
.6
(4
9.
1–
54
.1
)
53
.3
(5
0.
8–
55
.9
)
52
.0
(4
9.
5–
54
.4
)
50
.0
(4
7.
9–
52
.1
)
79
.5
(7
5.
3–
83
.8
)
U
ni
ve
rs
ity
de
gr
ee
47
.9
(4
5.
2–
50
.5
)
50
.1
(4
7.
1–
53
.1
)
50
.2
(4
7.
3–
53
.2
)
55
.0
(5
1.
7–
58
.3
)
51
.9
(4
8.
1–
55
.7
)
49
.3
(4
5.
9–
52
.7
)
83
.0
(7
8.
9–
87
.0
)
C
ha
ng
es
du
rin
g
th
e
la
st
3
m
on
th
s
N
o
ch
an
ge
s
on
tr
ea
tm
en
t
47
.2
(4
5.
4–
48
.9
)
50
.4
(4
8.
5–
52
.3
)
50
.8
(4
9.
2–
52
.4
)
53
.9
(5
2.
2–
55
.6
)
52
.2
(5
0.
4–
53
.9
)
50
.2
(4
8.
7–
51
.7
)
81
.6
(7
8.
9–
84
.2
)
C
ha
ng
es
on
di
et
/n
ut
rit
io
n
42
.4
(3
7.
8–
46
–9
)
45
.7
(4
2.
2–
49
.3
)
50
.1
(4
6.
5–
53
.8
)
51
.6
(4
7.
2–
61
.6
)
50
.6
(4
6.
6–
54
.7
)
46
.7
(4
2.
6–
50
.9
)
71
.7
(6
3.
7–
79
.6
)
Bo
lu
s
ca
lc
ul
at
or
42
.2
(3
6.
0–
48
.3
)
46
.4
(3
9.
6–
53
.1
)
47
.1
(4
0.
9–
53
.4
)
52
.1
(4
3.
2–
61
.1
)
51
.0
(4
3.
2–
58
.8
)
46
.1
(3
8.
1–
54
.1
)
77
.2
(7
8.
0–
86
.4
)
H
yp
og
ly
ce
m
ia
Ye
s
51
.8
(4
0.
3–
63
.2
)
60
.5
(5
3.
1–
68
.0
)
49
.2
(4
5.
2–
53
.1
)
57
.9
(4
8.
5–
67
.4
)
65
.5
(6
0.
1–
70
.9
)
59
.9
(5
2.
0–
67
.7
)
90
.6
(8
6.
0–
95
.2
)
N
o
46
.3
(4
4.
6–
47
.9
)
49
.4
(4
7.
7–
51
.1
)
50
.6
(4
9.
1–
52
.0
)
53
.5
(5
1.
9–
55
.1
)
51
.7
(5
0.
1–
53
.3
)
49
.4
(4
8.
0–
50
.8
)
79
.9
(7
7.
4–
82
.5
)
H
yp
er
gl
yc
em
ia
Ye
s
41
.9
(3
5.
3–
48
.4
)
45
.4
(3
7.
9–
52
.9
)
50
.2
(4
6.
3–
54
.2
)
50
.0
(4
2.
7–
57
.4
)
50
.7
(4
4.
1–
57
.4
)
47
.2
(4
1.
8–
52
.7
)
70
.2
(5
8.
9–
81
.4
)
N
o
46
.8
(4
5.
1–
48
.4
)
50
.0
(4
8.
3–
51
.7
)
50
.6
(4
9.
1–
52
.1
)
53
.9
(5
2.
3–
55
.5
)
52
.1
(5
0.
4–
53
.8
)
49
.8
(4
8.
3–
51
.3
)
81
.0
(7
8.
4–
83
.5
)
H
bA
c1 >
7.
5%
(5
8
m
m
ol
/m
ol
)
44
.3
(4
2.
1–
46
.9
)
48
.4
(4
6.
0–
50
.8
)
49
.7
(4
7.
9–
51
.5
)
51
.9
(4
8.
9–
53
.2
)
51
.1
(4
8.
9–
53
.2
)
48
.0
(4
6.
3–
49
.6
)
77
.3
(7
3.
4–
81
.1
)
≤7
.5
%
(5
8
m
m
ol
/m
ol
)
48
.3
(4
6.
1–
50
.6
)
50
.8
(4
8.
5–
53
.2
)
51
.3
(4
9.
2–
53
.4
)
55
.2
(5
3.
1–
57
.4
)
52
.9
(5
0.
6–
55
.3
)
51
.2
(4
8.
9–
53
.4
)
82
.9
(7
9.
7–
86
.0
)
Ti
m
e
w
/d
ia
gn
os
es
≤5
ye
ar
s
47
.5
(4
5.
4–
49
.5
)
50
.6
(4
8.
6–
52
.6
)
51
.0
(4
9.
4–
52
.6
)
54
.8
(5
2.
9–
56
.8
)
52
.9
(5
0.
8–
54
.9
)
50
.7
(4
8.
8–
52
.5
)
79
.9
(7
6.
9–
83
.0
)
>
5
ye
ar
s
44
.8
(4
2.
2–
47
.4
)
48
.2
(4
5.
3–
51
.1
)
49
.8
(4
7.
2–
52
.4
)
51
.8
(4
9.
2–
54
.4
)
50
.8
(4
8.
3–
53
.3
)
48
.0
(4
5.
8–
50
.2
)
80
.5
(7
6.
1–
84
.9
)
A
dh
er
en
ce
H
ig
h
48
.6
(4
6.
6–
50
.6
)
51
.2
(4
8.
7–
53
.1
)
50
.4
(4
8.
5–
52
.6
)
54
.0
(5
1.
6–
56
.5
)
52
.6
(5
0.
1–
55
.1
)
51
.1
(4
8.
9–
53
.3
)
82
.7
(7
9.
5–
85
.8
)
Lo
w
43
.9
(4
1.
8–
46
.1
)
48
.2
(4
6.
1–
50
.3
)
50
.5
(4
8.
5–
52
.3
)
53
.1
(5
1.
2–
55
.0
)
51
.4
(4
9.
4–
53
.4
)
48
.3
(4
6.
6–
50
.1
)
78
.2
(7
4.
4–
82
.4
)
Murillo et al. BMC Pediatrics  (2017) 17:16 Page 5 of 9
Other studies had already linked a worse HRQOL in
children with specific characteristics such as those from
single-parent families or families with disadvantaged
socioeconomic status [23, 24]. The results of the present
study reinforce this finding and the importance of knowing
the social situation of the patient. One of the main findings
indicates the need to provide special reinforcement in
monoparental families at younger ages.
Evidence shows that better HRQOL is associated with
better metabolic control although this relationship is
modest [20, 21, 25, 26]. In our study it was also found
an association between HRQOL and HbA1c; nevertheless,
it is not possible to establish the directionality of association
given the cross-sectional design of the analysis. Some
studies suggest that the experience of having suffered
severe hypoglycemia can affect HRQOL for fear of
their recurrence [27]. In our study patients who had
suffered significant hypoglycemia showed better scores
in almost all dimensions of HRQOL, although these
data are not valuable because of the small number of
patients experiencing hypoglycemia. On the other
hand, in general almost all patients were well con-
trolled as it was reflected by the relatively few patients
in the higher extreme of the curve distribution of
HbA1c. This fact could be associated to the almost
universal healthcare coverage and easy access to
Table 3 Standardized mean differences (effect size, ES) according to sociodemographic and clinical variables
Physical well being Psychological well-being Parents/Autonomy Peers School KIDSCREEN-10 index VAS
Age
8–11ya 0.34 0.39 0.04 0.26 0.58 0.61 0.56
12–19y
Sex
Boys –0.27 −0.05 0.10 −0.10 0.48 0.005 0.0001
Girlsa
Type of family
Biparentala 0.67 0.21 0.26 0.37 0.24 0.30 0.42
Monoparental
Primary school 0.29 0.13 0.10 0.25 0.03 0.01 0.21
Secondary school 0.16 0.002 0.14 0.20 0.06 0.09 0.21
University degreea
Changes during the last 3 months
No changes on treatmenta
Changes on diet/nutrition 0.54 0.48 0.06 0.24 0.15 0.43 0.70
Bolus calculator 0.54 0.40 0.43 0.18 0.12 0.51 0.32
Hypoglycemia
Yesa 0.37 1.16 −0.16 0.49 1.52 1.28 −0.34
No
Hyperglycemia
Yesa −0.61 −0.47 −0.03 −0.41 −0.14 −0.31 −1.02
No
HbAc1
> 7.5% (58 mmol/mol)a −0.5 −0.23 −0.17 −0.33 −0.18 −0.38 −0.40
≤7.5% (58 mmol/mol)
Time w/diagnoses
≤5 yearsa 0.23 0.24 0.14 0.32 0.21 0.32 −0.02
> 5 years
Adherence
Higha 0.53 0.31 0.01 0.10 0.12 0.33 0.30
Low
aReference category. Statistically significant ES are shown in bold
KIDSCREEN-27, KIDSCREEN-10 Index and Visual analogue scale (VAS)
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healthcare services and programmes in Spain, which
facilitates disease control.
Adherence to treatment is very important to achieve a
good metabolic control and it could be associated to
HRQOL [21]. Our study shows similar results than a
prospective study, with worse HRQOL in patients with a
lower level of adherence [28]. Moreover, patients on pump
therapy, requiring a very high level of adhesion, have been
linked to improved quality of life [29, 30]. In our case we
have not been able to analyze the characteristics of this
treatment given the small number of patients.
Patients with poor mental health also show lower
HRQOL scores in our study. This figures are similar
than other studies in which diabetic patients have a
high incidence of depression, anxiety and other psy-
chological problems [24, 31, 32]. In this sense, the role
of clinical psychologist could be important in order to
reinforce those positive emotional and psychological
aspects that are potentially modifiable in this group of
patients [33]. Mental health and adherence were
among the factors associated with HRQOL, therefore,
are aspects to consider and evaluate regularly in diabetic
patients, in addition to metabolic control.
The study has several limitations. Firstly, 35% of
patients who did not enter the study could lead to a
selection bias. Although there were no differences
between these patients and those who participated in
terms of age or years of evolution of the disease, we
didn’t know the metabolic control of some of them.
Perhaps some had higher levels of HbA1c and therefore
would not participate. Secondly, patients were recruited
from 5 different centers, so that personal characteristics,
clinical factors and treatment received may vary the
results. However, no significant differences were found
in the multivariate models when entering the center or
pediatrician (data not shown). Thirdly, the results, in
part may be related to the HRQOL instruments used
in each study. HRQOL studies in pediatric patients with
T1DM have used different measurement instruments,
some disease-specific, such as diabetes DISABKIDS module
[34], or the Peds-QL [35].
One of the strengths of the study is the use of the
KIDSCREEN and the EQ-5D-Y simultaneously, two
generic HRQOL instruments for children. Thus, it has
been possible to compare the HRQOL of this group of
patients with the normative KIDSCREEN Spanish and
European data and allowed us to estimate the impact
comparing with the general population of the same age
and sex. Moreover, it is currently not possible to calcu-
late the Quality Adjusted Life Years (QALYs) or a simi-
lar indicator necessary to carry out a cost-effectiveness
analysis due to the lack of developed preference-values
in the Spanish population of this age group. The present
study attempts to provide initial data to carry out such
studies, which are scarce and necessary in childhood
population. On the other hand, it was not included a
specific HRQOL instrument in T1DM due to the lack
of such instruments adapted into Spanish population of
this age group. However both the KIDSCREEN and the
EQ-5D-Y as generic instruments have been widely used
in general healthy population as well as various health
problems. Both instruments have demonstrated accept-
able discrimination ability to study the impact of health
problems on HRQOL. In addition, the availability of
reference values has allowed us to use the European
general population norms of the KIDSCREEN and
compare with the sample with acceptable accuracy and
easy interpretation. Finally, it has not been possible to
include a standardized adherence measure given the
lack of instruments adapted in Spain. However the variables
Table 4 Multiple linear regression models of the KIDSCREEN-27, KIDSCREEN-10 Index and Visual analogue Scale (VAS)
Physical
well- being
B (SE)
Psychological
well-being
B (SE)
Parents relationship
B (SE)
Peers
B (SE)
School
B (SE)
KIDSCREEN-10
B (SE)
VAS
B (SE)
Sociodemographics
Sex (boys) - - - - −4.46 (1.52)a - -
Age - - 0.21 (0.08)a - −0.93 (0.25)a -
-Type of family (monoparental) - - - - −15.2 (4.05)a -
Clinical variables-
Adherence (high) 4.34 (1.48)a - - - - -
Mental health (SDQ) - −0.96 (0.13)a −0.46 (0.12)a −0.71 (0.13)a −0.63 (0.14)a −0.7 (0.11)a −0.62 (0.22)a
Interaction terms
Age by type of family - 1.02 (0.26)a
Adjusted R2 0.15 0.29 0.12 0.17 0.16 0.30 0.08
Reference category: girls; biparental family; adherence: low. Models are adjusted for the rest of variables in the Table and also level of education, origin, body
mass index, time w/ diagnoses, and HBA1c
VAS Visual analogue scale, B beta coefficient, SE Standard error, SDQ Strengths and diffitulties questionnaire (total difficulties score)
aStatistically significant at 0.001 level according to Bonferroni correction
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used have yielded an assessment of adherence acceptably.
Future studies should incorporate valid and reliable
measures of this factor with potential utility in the daily
clinical management.
Conclusions
In summary, HRQOL in children and adolescents with
T1DM were similar than the general population of the
same age and gender, with slightly lower physical well-
being. We have demonstrated the feasibility to assess
HRQOL through the use of new technologies such as
the Internet, which could provide essential elements in rou-
tine visits in the pediatric and adolescent diabetic patients.
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